Skip to content

Released May 10, 2016, after the close

10-Q filed May 10, 2016, 40 days after period end · 0001390478-16-000110

Q1 2016 · 10-Q
Revenue—
Net Income-$16.49MN/M vs Q1 2015N/M vs Q4 2015
EPS, diluted—
Operating Income-$8,968,000N/M
Operating Cash Flow-$13,216,000N/M
Free Cash Flowderived-$13,222,000N/M

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ1 2016Q1 2015Q1 2014Q1 2013
Revenue—$2.75M$2.17M$2.75M
Net Income-$16.49M-$10.54M-$2.54M-$16.49M
EPS Diluted—-$0.08-$0.02-$0.11

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

SELLAS Life Sciences Group, Inc. · CIK 1390478 · Engraved from SEC EDGAR